Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 1;146(1):57-67.
doi: 10.1001/jamaoto.2019.3375.

Association of Subclinical Hearing Loss With Cognitive Performance

Affiliations

Association of Subclinical Hearing Loss With Cognitive Performance

Justin S Golub et al. JAMA Otolaryngol Head Neck Surg. .

Abstract

Importance: Age-related hearing loss (HL) is a common and treatable condition that has been associated with cognitive impairment. The level of hearing at which this association begins has not been studied to date.

Objective: To investigate whether the association between hearing and cognition is present among individuals traditionally classified as having normal hearing.

Design, setting, and participants: Cross-sectional study of 2 US epidemiologic studies (Hispanic Community Health Study [HCHS], 2008-2011, and National Health and Nutrition Examination Study [NHANES], 1999-2000, 2001-2002, and 2011-2012 cycles). The dates of analysis were November 2018 to August 2019. Multivariable generalized additive model (GAM) regression and linear regression were used to assess the association between HL (exposure) and cognition (outcome). Participants included 6451 individuals aged 50 years or older from the general Hispanic population (HCHS [n = 5190]) and the general civilian, noninstitutionalized US population (NHANES [n = 1261]).

Exposures: Audiometric HL (4-frequency pure-tone average).

Main outcomes and measures: Neurocognitive performance measured by the Digit Symbol Substitution Test (DSST) (score range, 0-113), Word Frequency Test (range, 0-49), Spanish-English Verbal Learning Test (SEVLT) 3 trials (range, 5-40), SEVLT recall (range, 0-15), and Six-Item Screener (range, 0-6); higher scores indicated better cognitive performance.

Results: Among 6451 individuals, the mean (SD) age was 59.4 (6.1) years, and 3841 (59.5%) were women. The GAM regression showed a significant inverse association between hearing and cognition across the entire spectrum of hearing after adjusting for demographics and cardiovascular disease. In separate multivariable linear regressions stratified by the classic binary definition of HL, decreased hearing was independently associated with decreased cognition in adults with normal hearing (pure-tone average ≤25 dB) across all cognitive tests in the HCHS. For example in this group, a 10-dB decrease in hearing was associated with a clinically meaningful 1.97-point (95% CI, 1.18-2.75) decrease in score on the DSST. When using a stricter HL cut point (15 dB), an association was also present in NHANES. The associations between hearing and cognition were stronger or equivalent in individuals with normal hearing than among those with HL. For example, there was a 2.28-point (95% CI, 1.56-3.00) combined cohort DSST score decrease per 10-dB decrease among individuals with normal hearing vs a 0.97-point (95% CI, 0.20-1.75) decrease among those with HL, with a significant interaction term between continuous and binary hearing.

Conclusions and relevance: An independent association was observed between cognition and subclinical HL. The association between hearing and cognition may be present earlier in HL than previously understood. Studies investigating whether treating HL can prevent impaired cognition and dementia should consider a lower threshold for defining HL than the current 25-dB threshold.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Golub reported receiving travel expenses for industry-sponsored events from Cochlear, Advanced Bionics, and Oticon Medical; consulting fees from Oticon Medical, Auditory Insight, Optinose, and Decibel Therapeutics; and honoraria from Abbott; and reported that his department received unrestricted educational grants from Storz, Stryker, Acclarent, 3NT, and Decibel Therapeutics. Dr Luchsinger reported being editor in chief of Alzheimer Disease & Associated Disorders and receiving a stipend from its publisher and reported being a paid consultant for vTv Therapeutics. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Flowchart of Participant Inclusion and Exclusion for Analysis
DSST indicates Digit Symbol Substitution Test; HCHS, Hispanic Community Health Study; and NHANES, National Health and Nutrition Examination Study. aIn NHANES, only individuals aged 60 to 69 years had both audiometry and cognitive testing. Therefore, we were restricted to this age range for our analysis.
Figure 2.
Figure 2.. Hearing vs Cognitive Performance in 2 US Cross-sectional Studies Assessed With GAM Regression
Linear regression was used for comparison. Multivariable models were adjusted for age, sex, educational level, and cardiovascular disease. The generalized additive model (GAM) regressions show that the association between hearing loss and cognition is not purely linear and that a stronger association between hearing loss and cognition may exist among individuals with normal hearing than those among those with HL. The SE CIs are in orange shading. HCHS indicates Hispanic Community Health Study; NHANES, National Health and Nutrition Examination Study; and SEVLT, Spanish-English Verbal Learning Test. aStatistically significant for linear regression and GAM regression, except the multivariable models for the digit symbol substitute test in NHANES; coefficients and 95% CIs are included in Table 2.
Figure 3.
Figure 3.. Hearing vs Cognitive Performance in 2 US Cross-sectional Studies, Assessed With Separate Multivariable Linear Regressions Among Participants With Normal Hearing vs Those With Hearing Loss
All models were adjusted for age, sex, educational level, and cardiovascular disease. HCHS indicates Hispanic Community Health Study; NHANES, National Health and Nutrition Examination Study; and SEVLT, Spanish-English Verbal Learning Test. aStatistically significant for a hearing stratum; coefficients and 95% CIs are included in Table 2. bStatistically significant for a difference between the 2 hearing strata; coefficients and 95% CIs are included in eTable 3 in the Supplement.

Comment in

  • Reconsidering Individuals With Normal Hearing.
    Powell DS, Deal JA, Goman AM. Powell DS, et al. JAMA Otolaryngol Head Neck Surg. 2020 Jan 1;146(1):67-68. doi: 10.1001/jamaoto.2019.3372. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31725835 Free PMC article. No abstract available.

References

    1. Goman AM, Lin FR. Prevalence of hearing loss by severity in the United States. Am J Public Health. 2016;106(10):1820-1822. doi:10.2105/AJPH.2016.303299 - DOI - PMC - PubMed
    1. Chien W, Lin FR. Prevalence of hearing aid use among older adults in the United States. Arch Intern Med. 2012;172(3):292-293. doi:10.1001/archinternmed.2011.1408 - DOI - PMC - PubMed
    1. Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess. 2007;11(42):1-294. doi:10.3310/hta11420 - DOI - PubMed
    1. Golub JS, Luchsinger JA, Manly JJ, Stern Y, Mayeux R, Schupf N. Observed hearing loss and incident dementia in a multiethnic cohort. J Am Geriatr Soc. 2017;65(8):1691-1697. doi:10.1111/jgs.14848 - DOI - PMC - PubMed
    1. Loughrey DG, Kelly ME, Kelley GA, Brennan S, Lawlor BA. Association of age-related hearing loss with cognitive function, cognitive impairment, and dementia: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018;144(2):115-126. doi:10.1001/jamaoto.2017.2513 - DOI - PMC - PubMed

Publication types